• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱氨酸肽酶在造血干细胞分化及免疫系统功能调节中的作用

The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.

作者信息

Perišić Nanut Milica, Pečar Fonović Urša, Jakoš Tanja, Kos Janko

机构信息

Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.

Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Front Immunol. 2021 Jul 15;12:680279. doi: 10.3389/fimmu.2021.680279. eCollection 2021.

DOI:10.3389/fimmu.2021.680279
PMID:34335582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8322073/
Abstract

Cysteine cathepsins are primarily involved in the degradation and recycling of proteins in endo-lysosomal compartments but are also gaining recognition as pivotal proteolytic contributors to various immune functions. Through their extracellular proteolytic activities within the hematopoietic stem cell niche, they are involved in progenitor cell mobilization and differentiation. Cysteine cathepsins, such as cathepsins L and S contribute to antigen-induced adaptive immunity through major histocompatibility complex class II antigen presentation whereas cathepsin X regulates T-cell migration. By regulating toll-like receptor signaling and cytokine secretion cysteine cathepsins activate innate immune cells and affect their functional differentiation. Cathepsins C and H are expressed in cytotoxic T lymphocytes and natural killer cells and are involved in processing of pro-granzymes into proteolytically active forms. Cytoplasmic activities of cathepsins B and L contribute to the maintenance of homeostasis of the adaptive immune response by regulating cell death of T and B lymphocytes. The expression pattern, localization, and activity of cysteine cathepsins is tightly connected to their function in immune cells. Furthermore, cysteine cathepsins together with their endogenous inhibitors, serve as mediators in the interplay between cancer and immune cells that results in immune cell anergy. The aim of the present article is to review the mechanisms of dysregulation of cysteine cathepsins and their inhibitors in relation to immune dysfunction to address new possibilities for regulation of their function.

摘要

半胱氨酸组织蛋白酶主要参与内溶酶体区室中蛋白质的降解和循环利用,但作为各种免疫功能的关键蛋白水解因子也日益受到认可。通过其在造血干细胞龛内的细胞外蛋白水解活性,它们参与祖细胞的动员和分化。半胱氨酸组织蛋白酶,如组织蛋白酶L和S,通过主要组织相容性复合体II类抗原呈递促进抗原诱导的适应性免疫,而组织蛋白酶X调节T细胞迁移。通过调节Toll样受体信号传导和细胞因子分泌,半胱氨酸组织蛋白酶激活先天免疫细胞并影响其功能分化。组织蛋白酶C和H在细胞毒性T淋巴细胞和自然杀伤细胞中表达,并参与将前颗粒酶加工成蛋白水解活性形式。组织蛋白酶B和L的细胞质活性通过调节T和B淋巴细胞的细胞死亡,有助于维持适应性免疫反应的稳态。半胱氨酸组织蛋白酶的表达模式、定位和活性与其在免疫细胞中的功能紧密相关。此外,半胱氨酸组织蛋白酶与其内源性抑制剂一起,在癌症与免疫细胞之间的相互作用中充当介质,导致免疫细胞无反应性。本文的目的是综述半胱氨酸组织蛋白酶及其抑制剂失调与免疫功能障碍相关的机制,以探讨调节其功能的新可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/8322073/b35dd1fe7317/fimmu-12-680279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/8322073/293194dfada1/fimmu-12-680279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/8322073/b35dd1fe7317/fimmu-12-680279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/8322073/293194dfada1/fimmu-12-680279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/403a/8322073/b35dd1fe7317/fimmu-12-680279-g002.jpg

相似文献

1
The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.半胱氨酸肽酶在造血干细胞分化及免疫系统功能调节中的作用
Front Immunol. 2021 Jul 15;12:680279. doi: 10.3389/fimmu.2021.680279. eCollection 2021.
2
Cysteine Cathepsins in Tumor-Associated Immune Cells.肿瘤相关免疫细胞中的半胱氨酸组织蛋白酶。
Front Immunol. 2019 Aug 28;10:2037. doi: 10.3389/fimmu.2019.02037. eCollection 2019.
3
Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.半胱氨酸组织蛋白酶作为自然杀伤细胞和T细胞细胞毒性的调节因子。
Front Immunol. 2014 Dec 2;5:616. doi: 10.3389/fimmu.2014.00616. eCollection 2014.
4
Cystatin F as a regulator of immune cell cytotoxicity.胱抑素 F 作为免疫细胞细胞毒性的调节剂。
Cancer Immunol Immunother. 2018 Dec;67(12):1931-1938. doi: 10.1007/s00262-018-2165-5. Epub 2018 May 10.
5
The role of cysteine proteinases and their inhibitors in the host-pathogen cross talk.半胱氨酸蛋白酶及其抑制剂在宿主-病原体相互作用中的作用。
Curr Protein Pept Sci. 2012 Dec;13(8):767-75. doi: 10.2174/138920312804871102.
6
Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells.胱抑素 F 水平升高与细胞毒性 T 细胞的细胞毒性降低相关。
Radiol Oncol. 2019 Mar 3;53(1):57-68. doi: 10.2478/raon-2019-0007.
7
Cysteine cathepsins: from structure, function and regulation to new frontiers.半胱氨酸组织蛋白酶:从结构、功能与调控到新前沿领域
Biochim Biophys Acta. 2012 Jan;1824(1):68-88. doi: 10.1016/j.bbapap.2011.10.002. Epub 2011 Oct 12.
8
Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease.哺乳动物的半胱氨酸肽酶:它们在健康和疾病状态下在口腔及其他组织中的生物学作用和潜在影响。
Crit Rev Oral Biol Med. 2002;13(3):238-75. doi: 10.1177/154411130201300304.
9
Cysteine cathepsins: regulators of antitumour immune response.半胱氨酸组织蛋白酶:抗肿瘤免疫反应的调节因子。
Expert Opin Biol Ther. 2006 Dec;6(12):1295-309. doi: 10.1517/14712598.6.12.1295.
10
Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells.组织蛋白酶 S、D 和半胱氨酸蛋白酶抑制剂 C 协调参与造血干细胞向树突状细胞的定向分化。
Int J Biochem Cell Biol. 2011 May;43(5):775-83. doi: 10.1016/j.biocel.2011.02.001. Epub 2011 Feb 17.

引用本文的文献

1
Genomic regions associated with bovine respiratory disease in pacific northwest Holstein cattle.与太平洋西北地区荷斯坦奶牛牛呼吸道疾病相关的基因组区域。
Front Vet Sci. 2025 Jul 31;12:1637087. doi: 10.3389/fvets.2025.1637087. eCollection 2025.
2
O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review).O-连接的N-乙酰葡糖胺化作为胆管癌治疗的新兴分子靶点(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8952. Epub 2025 Jul 19.
3
NFĸB and its inhibitors in preeclampsia: mechanisms and potential interventions.

本文引用的文献

1
The Carboxypeptidase Activity of Cathepsin X is not Controlled by Endogenous Inhibitors.组织蛋白酶X的羧肽酶活性不受内源性抑制剂的调控。
Acta Chim Slov. 2019 Feb;66(1):58-61.
2
Age-Related Gene Alteration in Naïve and Memory T cells Using Precise Age-Tracking Model.使用精确年龄追踪模型研究初始T细胞和记忆T细胞中与年龄相关的基因改变。
Front Cell Dev Biol. 2021 Feb 11;8:624380. doi: 10.3389/fcell.2020.624380. eCollection 2020.
3
Fetal liver hematopoiesis: from development to delivery.胎儿肝脏造血:从发育到分娩。
核因子κB及其抑制剂在子痫前期中的作用机制与潜在干预措施
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 29. doi: 10.1007/s00210-025-04211-x.
4
Cathepsins: Emerging targets in the tumor ecosystem to overcome cancers.组织蛋白酶:肿瘤生态系统中克服癌症的新兴靶点。
Semin Cancer Biol. 2025 Jul;112:150-166. doi: 10.1016/j.semcancer.2025.04.001. Epub 2025 Apr 12.
5
Causal effect of immune cells, metabolites, cathepsins, and vitamin therapy in diabetic retinopathy: a Mendelian randomization and cross-sectional study.免疫细胞、代谢物、组织蛋白酶和维生素治疗在糖尿病视网膜病变中的因果作用:孟德尔随机化和横断面研究。
Front Immunol. 2024 Oct 1;15:1443236. doi: 10.3389/fimmu.2024.1443236. eCollection 2024.
6
Multi-omic profiling of pathogen-stimulated primary immune cells.病原体刺激的原代免疫细胞的多组学分析。
iScience. 2024 Jul 6;27(8):110471. doi: 10.1016/j.isci.2024.110471. eCollection 2024 Aug 16.
7
Machine Learning-Directed Conversion of Glioblastoma Cells to Dendritic Cell-Like Antigen-Presenting Cells as Cancer Immunotherapy.机器学习引导的胶质母细胞瘤细胞向树突状细胞样抗原呈递细胞的转化作为癌症免疫疗法
Cancer Immunol Res. 2024 Oct 1;12(10):1340-1360. doi: 10.1158/2326-6066.CIR-23-0721.
8
Different glycosylation profiles of cystatin F alter the cytotoxic potential of natural killer cells.胱抑素 F 的不同糖基化谱改变了自然杀伤细胞的细胞毒性潜力。
Cell Mol Life Sci. 2023 Dec 13;81(1):8. doi: 10.1007/s00018-023-05041-x.
9
Structural Transitions of Papain-like Cysteine Proteases: Implications for Sensor Development.木瓜蛋白酶样半胱氨酸蛋白酶的结构转变:对传感器开发的启示
Biomimetics (Basel). 2023 Jul 1;8(3):281. doi: 10.3390/biomimetics8030281.
10
Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications.基于动脉粥样硬化的心血管疾病中多功能半胱氨酸组织蛋白酶概述:从分子功能洞察到临床意义
Cell Biosci. 2023 May 19;13(1):91. doi: 10.1186/s13578-023-01040-4.
Stem Cell Res Ther. 2021 Feb 17;12(1):139. doi: 10.1186/s13287-021-02189-w.
4
Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity.细胞毒性T淋巴细胞可摄取细胞外的胱抑素F,并降低其细胞毒性。
Cancers (Basel). 2020 Dec 6;12(12):3660. doi: 10.3390/cancers12123660.
5
Lysosomal quality control of cell fate: a novel therapeutic target for human diseases.溶酶体质量控制细胞命运:人类疾病的新治疗靶点。
Cell Death Dis. 2020 Sep 30;11(9):817. doi: 10.1038/s41419-020-03032-5.
6
Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages.组织蛋白酶抑制可调节肿瘤相关巨噬细胞的代谢和极化。
Cancers (Basel). 2020 Sep 10;12(9):2579. doi: 10.3390/cancers12092579.
7
Identification of Novel Molecular Markers of Human Th17 Cells.鉴定人 Th17 细胞的新型分子标记物。
Cells. 2020 Jul 3;9(7):1611. doi: 10.3390/cells9071611.
8
Cortical Thymocytes Along With Their Selecting Ligands Are Required for the Further Thymic Maturation of NKT Cells in Mice.皮质胸腺细胞及其选择配体是小鼠 NKT 细胞进一步胸腺成熟所必需的。
Front Immunol. 2020 May 7;11:815. doi: 10.3389/fimmu.2020.00815. eCollection 2020.
9
Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells.半胱氨酸组织蛋白酶 L 和 X 可差异调节髓源性抑制细胞与肿瘤细胞之间的相互作用。
Cancer Immunol Immunother. 2020 Sep;69(9):1869-1880. doi: 10.1007/s00262-020-02592-x. Epub 2020 May 5.
10
Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction.组织蛋白酶B通过与NLRP3相互作用,在巨噬细胞的NLRP3炎性小体激活中发挥作用。
Front Cell Dev Biol. 2020 Mar 31;8:167. doi: 10.3389/fcell.2020.00167. eCollection 2020.